Hip Implants Market is expected to reach US$ 12.04 Billion by 2034

Total Hip Replacement Segment Drives Hip Implants Market Growth

According to our new research study named "Hip Implants Market Forecast to 2034 – Global Analysis – by Product Type, Material Type, End User, and Geography," the market was valued at US$ 8.27 billion in 2025 and is projected to reach US$ 12.04 billion by 2034; it is expected to register a CAGR of 4.3% during 2026–2034. The growing aging population, increasing prevalence of osteoarthritis, and surge in trauma, obesity, and lifestyle-related injuries drive the adoption of hip implants. Adoption of ceramic-on-polyethylene and hybrid implants, proliferation of robotic-assisted surgeries, and focus on cementless fixation techniques are projected to drive hip implants market trends in the coming years.

Hip implants are artificial devices replacing damaged hip joints, made of metal, ceramic, or plastic. They restore mobility, reduce pain, and improve the quality of life in patients with arthritis, fractures, or degenerative joint diseases. The rising elderly population and the growing number of osteoarthritis patients and hip fracture cases fuel demand for hip implant products, thereby driving the global hip implants market growth. Additionally, The market is supported by rising demand for minimally invasive procedures and the ongoing development of advanced implant materials. Improving healthcare infrastructure, higher patient awareness, and access to orthopedic treatments are contributing to the rising hip implants market size.

Hip Implants Market, by Region, 2025 (%)

Source: The Insight Partners Analysis

Hip Implants Market Analysis Based on Segmental Evaluation:

Based on product type, the hip implants market is segmented into total hip replacement, partial hip replacement, hip resurfacing, and revision hip implant. The total hip replacement segment held a significant hip implants market share in 2025. The segment is experiencing strong growth because the procedure effectively relieves chronic pain while restoring mobility to patients who suffer from severe joint damage. The growing number of osteoarthritis cases, together with the increasing elderly population and the rising occurrence of hip fractures, serve as primary factors driving this trend. The development of new implant materials and surgical methods has enhanced implant longevity while decreasing patient recovery time, which makes the procedure more appealing to patients. The rising patient awareness, combined with better healthcare access and the existence of positive reimbursement systems, has led to increased total hip replacement surgery rates, which results in growing demand for this procedure.

The geographical scope of the hip implants market report encompasses an assessment of the market performance in North America, Europe, Asia Pacific, South America, Central America, the Middle East, and Africa. North America dominated the hip implants market share in 2025. Older adults develop medical conditions, including osteoarthritis and osteoporosis, and require surgical treatment for hip fractures. The increasing rates of obesity, together with the rise of inactive lifestyles, have led to more joint damage in younger people, which has resulted in higher patient numbers. Medical technological progress through advancements in minimally invasive surgery, superior implant materials, and extended lifespan prosthetics has resulted in better patient outcomes and shorter recovery periods, which has prompted more people to choose hip replacement surgery, boosting the hip implants market growth.

The US and Canada benefit from favorable reimbursement policies and strong healthcare systems, which make surgical procedures more accessible to patients. The increasing public understanding of joint health, combined with the introduction of early diagnostic methods, has resulted in improvements in medical treatment timing. Major medical device manufacturers conduct ongoing research and development, which leads to technical advancements that help North America maintain its leading position in the hip implants market.

Hip fractures and advanced OA drive demand for implants as the population ages and obesity rates rise, major risk factors noted by the CDC. The US Food and Drug Administration awarded Breakthrough Device Designation to Zimmer Biomet in October 2025 for its iodine-treated total hip replacement system, which represents the first such medical device. The development aims to decrease bacterial adhesion, which commonly leads to infections after surgical procedures. Recent advancements and better surgical techniques support better results for patients who experience hip joint degeneration and fractures.

The Mexican orthopedic and geriatric societies established joint quality indicators in 2025 to standardize fragility hip fracture treatment, which helps healthcare facilities decrease complications and achieve better patient results. Successful hip implant results depend on these guidelines, which cover essential elements such as surgery timing, infection control, and rehabilitation procedures. Public health initiatives aim to decrease obesity levels and prevent falls as a strategy to decrease OA and fracture occurrences. These disease burdens and innovations highlight the important role of hip implants in restoring mobility and quality of life for millions of people in the region. Hence, the above-mentioned factors collectively support the growth of the global hip implants market.

Zimmer Biomet Holdings Inc, Stryker Corp, Exactech Inc, B Braun SE, Smith & Nephew Plc, Corin Group, MatOrtho Limited, JointMedica, JRI Orthopaedics Limited, and Johnson & Johnson are among the leading companies profiled in the hip implants market report.

Based on product type, the hip implants market is divided into total hip replacement, partial hip replacement, hip resurfacing, and revision hip implant. In terms of material type, the market is segmented into metal-on-polyethylene, ceramic-on-ceramic, ceramic-on-metal, ceramic-on-polyethylene, and others. By end user, the market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, and others. Geographically, the hip implants market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com